PharMerica CORP Deferred Tax Assets, Net of Valuation Allowance
PharMerica CORP had Deferred Tax Assets, Net of Valuation Allowance of $1.80 million as of 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2017-11-09
- 2017-09-30: Deferred Tax Assets, Net of Valuation Allowance $1.80M.
- 2017-06-30: Deferred Tax Assets, Net of Valuation Allowance $1.80M.
- 2017-03-31: Deferred Tax Assets, Net of Valuation Allowance $6.30M.
- 2016-12-31: Deferred Tax Assets, Net of Valuation Allowance $9.20M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance | Deferred Tax Assets, Net of Valuation Allowance as first filed |
|---|---|---|
| 2017-09-30 | $1.80M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $1.80M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $6.30M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $9.20M 10-Q · filed 2017-11-09 | |
| 2016-09-30 | $13.00M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $13.30M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $17.90M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $21.10M 10-K · filed 2017-02-24 | |
| 2015-09-30 | $23.00M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $27.80M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $28.10M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $27.10M 10-K · filed 2016-02-26 | $30.60M 10-K · filed 2015-03-02 |
| 2014-09-30 | $28.60M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $17.40M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $14.20M 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $18.20M 10-K · filed 2015-03-02 | |
| 2013-09-30 | $19.70M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $22.70M 10-Q · filed 2013-08-02 | |
| 2013-03-31 | $22.00M 10-Q · filed 2013-05-01 | |
| 2012-12-31 | $26.10M 10-K · filed 2014-02-28 | $25.60M 10-K · filed 2013-02-07 |
| 2012-09-30 | $33.20M 10-Q · filed 2012-11-01 | |
| 2012-06-30 | $31.10M 10-Q · filed 2012-08-02 | |
| 2011-12-31 | $37.10M 10-K · filed 2013-02-07 |